Diagnosis of placental mesenchymal dysplasia with magnetic resonance imaging
Placental mesenchymal dysplasia (PMD) is a rare condition characterized by placental enlargement, dilatation and congestion of the chorionic plate vessels, and stem villous edema but without signs of trophoblastic proliferation. The final diagnosis requires macro-and microscopic examination of the placenta by a pathologist. Its incidence has been estimated to be 0.02% per examined placenta 1 . Following a systematic review in 2013 2 , it was reported that PMD resulted in an uncomplicated pregnancy and birth of a healthy infant in 9% of cases. However, high figures of spontaneous preterm delivery (33%), intrauterine growth restriction (33%) and intrauterine fetal death (13%) were reported. Moreover, in about 20% of cases, the fetus had Beckwith-Wiedemann syndrome (BWS). Other observed complications included neonatal hepatic tumors, anemia and thrombocytopenia, and maternal hypertension was diagnosed in about 10% of cases.
A correct diagnosis of PMD is a prerequisite for being able to provide optimal information to the patient as well as for adequate surveillance and management. In the event that the woman opts to continue her pregnancy, monitoring should include estimation of fetal growth and Doppler assessment, due to the risk of intrauterine growth restriction and intrauterine fetal death, as well as Doppler assessment of the fetal middle cerebral artery due to the risk of anemia. The sonographic findings of PMD are reminiscent of a molar pregnancy. A complete mole, however, has no fetus. A partial mole is most often associated with triploidy and can thus be diagnosed via an invasive procedure. The real challenge is to differentiate PMD from a twin pregnancy with a complete mole and a normal fetus. Such pregnancies are sonographically similar to those with PMD, both having a living fetus and a large multicystic placenta. The karyotype is most often normal in both of these kinds of pregnancies. Maternal serum human chorionic gonadotropin (hCG) may be elevated in cases with PMD but seldom reaches values as high as those in a molar pregnancy, and alpha fetoprotein (AFP) in maternal serum is also often elevated in PMD. Color Doppler can be of help 3 , and MRI has the potential to be an important diagnostic tool 4 , as demonstrated by the following case.
A healthy 31-year-old primiparous woman presented for antenatal care at 12 weeks' gestation. Routine ultrasound examination at 18 + 2 weeks was normal, including fetal size, organs and placenta. At 23 weeks, the patient complained of abdominal pain, aggravated by movement. Her symptoms were interpreted as symphysiolysis. Assessment at 26 + 3 weeks revealed that she had gained 12 kg in weight since measurement at 12 weeks, and the symphysis-fundus distance was substantially increased. Uterine contractions were added to her previous symptoms. A second ultrasound examination was performed, showing an abnormally large placenta with hypoechogenic areas. One week later, at 27 + 4 weeks, this finding was verified by a specialist in fetal medicine. The placenta was described as enlarged and cystic with increased vascularity (Figure 1) . The fetus was normal in size, amniotic fluid volume was within normal limits, as was umbilical artery pulsatility index. A twin pregnancy with a complete mole was suspected. Two days later, magnetic resonance tomography showed a large placenta, which engrossed most of the uterine cavity. The greater part of the placenta was highly inhomogeneous with cysts and wide vessels, with only a minor part appearing normal. No signs of outgrowth were observed ( Figure 2 ) and the tentative diagnosis was not changed.
At 28 + 3 weeks, the woman presented with premature rupture of the membranes and uterine contractions, and an emergency Cesarean section was performed due to suspicion of placental abruption. A female neonate was delivered, weighing 1055 g, which was appropriate for gestational age. Her Apgar scores were 6, 9 and 10 at 1, 5 and 10 min, respectively. The placenta weighed 1360 g with a thickness of 4 cm and contained multiple large cysts and rounded tumor-like structures. Aneurysmal dilated vessels were seen on the fetal surface. Histological examination showed enlarged and hydropic stem villi without trophoblastic proliferation and the tumor structures had chorangioma-like vascular proliferations ( Figure 3 ). Both macroscopic and histological appearances were consistent with PMD.
The infant had anemia, requiring a blood transfusion, and thrombocytopenia, which normalized spontaneously. She had three skin and several liver hemangiomas but did not fulfill the criteria for BWS. Two skin hemangiomas were resected, and a transdermal needle biopsy of one liver hemangioma was performed. Genetic analysis of the PMD part of the placenta and the hemangiomas revealed an andrenogenetic/biparental mosaicism. Hence, in a subset of the diploid cells, both chromosomes were derived from the father (paternal uniparental disomy). The infant had developed normally at 3 years of age, however surveillance, including abdominal ultrasound every 3 months, is ongoing.
Suspicion of PMD is most often raised at an ultrasound examination. Biochemical markers, such as serum hCG and AFP, karyotype and color Doppler findings can be diagnostic aids. MRI has the advantage of very high image contrast with excellent contrast between the fluid and soft tissues. Moreover, it is much less dependent on the habitus of the woman and can produce high-quality images even in cases of oligohydramnios 5 . MRI findings of PMD have been described previously 4 as an enlarged placenta with inhomogeneous signals and dilated placental vessels. In PMD, the placenta should be located within the fetal sac, as opposed to a twin pregnancy with a fetus and a complete mole in which it is located outside the sac. Although the correct diagnosis was not reached prospectively in our case, retrospective review of the images showed that all these signs could be observed (Figure 2) , thus a correct diagnosis should have been possible.
As shown in our case, MRI has the potential to be a useful tool for the differential diagnosis of PMD and should help inform appropriate management. 
